Company: WHWK
Filing Date: 2025-03-04
Form Type: 8-K
Source: 0001193125-25-045605
Chunk: 2

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-03-04
Form: 8-K
Item: Item 7.01
Chunk 2
---
Item 7.01 Regulation FD Disclosure.

On March 4, 2025, the Company issued a press release announcing the closing of the PIPE Financing. The press release is attached as Exhibit 99.1 to this report and incorporated into this Item 7.01 by reference.

The information in this Item 7.01, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

  Exhibit      Description                                                                                     
                                                                                                               
   Number                                                                                                      
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────
     10.1      Registration Rights Agreement, by and among Aadi Biosciences, Inc. and the purchasers thereto.  
     10.2      Amended and Restated 2021 Equity Incentive Plan.                                                
     99.1      Press Release, dated March 4, 2025                                                              
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)